Literature DB >> 20652086

Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy.

Jonathan D Moreno1, Colleen E Clancy.   

Abstract

The use of computational modeling to predict arrhythmia and arrhythmogensis is a relatively new field, but has nonetheless dramatically enhanced our understanding of the physiological and pathophysiological mechanisms that lead to arrhythmia. This review summarizes recent advances in the field of computational modeling approaches with a brief review of the evolution of cellular action potential models, and the incorporation of genetic mutations to understand fundamental arrhythmia mechanisms, including how simulations have revealed situation specific mechanisms leading to multiple phenotypes for the same genotype. The review then focuses on modeling drug blockade to understand how the less-than-intuitive effects some drugs have to either ameliorate or paradoxically exacerbate arrhythmia. Quantification of specific arrhythmia indicies are discussed at each spatial scale, from channel to tissue. The utility of hERG modeling to assess altered repolarization in response to drug blockade is also briefly discussed. Finally, insights gained from Ca(2+) dynamical modeling and EC coupling, neurohumoral regulation of cardiac dynamics, and cell signaling pathways are also reviewed.

Entities:  

Year:  2009        PMID: 20652086      PMCID: PMC2905809          DOI: 10.1016/j.ddmod.2010.03.001

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN: 1740-6757


  117 in total

1.  Period-doubling instability and memory in cardiac tissue.

Authors:  Jeffrey J Fox; Eberhard Bodenschatz; Robert F Gilmour
Journal:  Phys Rev Lett       Date:  2002-09-09       Impact factor: 9.161

2.  Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.

Authors:  Jeffrey J Saucerman; Andrew D McCulloch
Journal:  Prog Biophys Mol Biol       Date:  2004 Jun-Jul       Impact factor: 3.667

3.  Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study.

Authors:  Z Qu; J N Weiss; A Garfinkel
Journal:  Am J Physiol       Date:  1999-01

4.  Improved guinea-pig ventricular cell model incorporating a diadic space, IKr and IKs, and length- and tension-dependent processes.

Authors:  D Noble; A Varghese; P Kohl; P Noble
Journal:  Can J Cardiol       Date:  1998-01       Impact factor: 5.223

Review 5.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

Authors:  D M Roden; R Lazzara; M Rosen; P J Schwartz; J Towbin; G M Vincent
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

6.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

7.  The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.

Authors:  H L Greene; D M Roden; R J Katz; R L Woosley; D M Salerno; R W Henthorn
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

Review 8.  Computational models of the heart and their use in assessing the actions of drugs.

Authors:  Denis Noble
Journal:  J Pharmacol Sci       Date:  2008-06       Impact factor: 3.337

9.  What happens when cardiac Na channels lose their function? 1--numerical studies of the vulnerable period in tissue expressing mutant channels.

Authors:  C Frank Starmer; Thomas J Colatsky; Augustus O Grant
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.

Authors:  Marco Mongillo; Theresa McSorley; Sandrine Evellin; Arvind Sood; Valentina Lissandron; Anna Terrin; Elaine Huston; Annette Hannawacker; Martin J Lohse; Tullio Pozzan; Miles D Houslay; Manuela Zaccolo
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

View more
  7 in total

Review 1.  Cardiac models in drug discovery and development: a review.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Crit Rev Biomed Eng       Date:  2011

2.  Inter-individual variability in the pre-clinical drug cardiotoxic safety assessment--analysis of the age-cardiomyocytes electric capacitance dependence.

Authors:  Sebastian Polak; Kamil Fijorek
Journal:  J Cardiovasc Transl Res       Date:  2012-03-13       Impact factor: 4.132

3.  Confocal Microscopy-Based Estimation of Parameters for Computational Modeling of Electrical Conduction in the Normal and Infarcted Heart.

Authors:  Joachim Greiner; Aparna C Sankarankutty; Gunnar Seemann; Thomas Seidel; Frank B Sachse
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

4.  Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems.

Authors:  Aslak Tveito; Karoline Horgmo Jæger; Nathaniel Huebsch; Bérénice Charrez; Andrew G Edwards; Samuel Wall; Kevin E Healy
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

5.  A Molecularly Detailed NaV1.5 Model Reveals a New Class I Antiarrhythmic Target.

Authors:  Jonathan D Moreno; Wandi Zhu; Kathryn Mangold; Woenho Chung; Jonathan R Silva
Journal:  JACC Basic Transl Sci       Date:  2019-10-28

6.  Effects of L-type calcium channel and human ether-a-go-go related gene blockers on the electrical activity of the human heart: a simulation study.

Authors:  Nejib Zemzemi; Blanca Rodriguez
Journal:  Europace       Date:  2014-09-15       Impact factor: 5.214

Review 7.  Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair.

Authors:  Xiao-Dong Zhang; Phung N Thai; Deborah K Lieu; Nipavan Chiamvimonvat
Journal:  Curr Cardiol Rep       Date:  2021-05-29       Impact factor: 2.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.